当前位置: 首页 > 期刊 > 《中西医结合心血管病》 > 202016
编号:13473139
呋塞米与托拉塞米治疗心力衰竭的疗效与安全性(2)
http://www.100md.com 2020年6月5日 《中西医结合心血管病电子杂志》 202016
     参考文献

    [1] 崔 炜.心力衰竭患者利尿剂抵抗的处理策略[J].中国心血管杂志,2015,20(01):1-3.

    [2] Lamb ED.Top 200 prescription drugs of 2008[EB/OL].http://www.pharmacytimes.com/issue/pharmacy/2009/2009-05/RxFocusTop200Drugs-0509.2009-05-15.

    [3] 曾 晶,鄧 阳,蔡骅琳,颜 苗,张毕奎,徐 萍.呋塞米片在中国健康受试者的生物等效性研究[J].中国临床药理学杂志,2016,32(20):1870-1872+1877.

    [4] 都 斌,姚雪艳.早期应用小剂量多巴胺联合呋塞米治疗心力衰竭的疗效[J].中国临床药理学杂志,2013,29(03):163-165.

    [5] ?ukasz J.Krzych,Piotr F.Czempik.Impact of furosemide on mortality and the requirement for renal replacement therapy in acute kidney injury:a systematic review and meta-analysis of randomised trials[J].Annals of Intensive Care,2019,9(1).

    [6] Chemlal Laila,Akachar Jihane,Makram Sanaa,Zoubir Brahim,Cherrah Yahia,Eljaoudi Rachid,Ibrahimi Azeddine,Faouzi Mly A.The displacement study of 99m Tc-DTPA-Human serum albumin binding in presence of furosemide and metformin by using equilibrium dialysis and molecular docking.[J].IUBMB life,2019,71(12).

    [7] Sherif Nourin Ali,Morra Mostafa Ebraheem,Thanh Le Van,Elsayed Ghadeer Gamal,et.Torasemide versus furosemide in treatment of heart failure:A systematic review and meta-analysis of randomized controlled trials.[J].Journal of evaluation in clinical practice,2019., http://www.100md.com(朱懿中)
上一页1 2